Home
News
Videos
Podcasts
Menu
Акционерное общество "ТВ БРИКС"
tvbrics@tvbrics.com
Рубцов переулок, д.13, Москва, 105082, RU
+74996425304
Currencies:
RUB/USD 0,0116
0,0001
BRL/USD 0,1923
0,0013
INR/USD 0,0105
0,0000
CNY/USD 0,1489
0,0001
ZAR/USD 0,0619
0,0007
IDR/USD 0,0001
0,0000
SPACE FOR MEDIA DIPLOMACY
21:20 «BRICSterview»
21:20 «BRICSterview»
Now 16+
21:20

«BRICSterview»

It is indicated Moscow time in the programme. Please take into account the time difference with your time zone.
21:50 «Russian Lessons with Tanya Semke»
Next
21:50

«Russian Lessons with Tanya Semke»

16+
22:05

Documentary film «Partitura. Young Music of Russia»

16+
23:00

«BRICSreport»

16+
Menu
Broadcast «BRICSterview»
RUB/USD
0,0116
0,0001
BRL/USD
0,1923
0,0013
INR/USD
0,0105
0,0000
CNY/USD
0,1489
0,0001
ZAR/USD
0,0619
0,0007
IDR/USD
0,0001
0,0000
TV BRICS Apps

Iran to fully meet insulin demand domestically within two years

Officials launch local production of insulin and plasma to strengthen national economy


Iran will be able to supply all of its insulin needs through domestic production within the next two years, following the launch of new manufacturing lines for insulin and plasma. This is reported by IRNA, a partner of TV BRICS.

The announcement was made by Mostafa Ghanei, Secretary of the Biotechnology Development Office of the Vice Presidency for Science and Technology, during a briefing on achievements in healthcare and medical equipment.

Ghanei noted that Iran currently spends over US$400 million annually on plasma imports, while insulin purchases abroad also represent a significant financial outflow. With the completion of the new production infrastructure, he said, the country will be capable of meeting its entire demand locally.

Ghanei also highlighted Iran’s leading role in biotechnology, stating that it holds the top position in the region and ranks fifth in Asia for biopharmaceutical production.

Photo: iStock / imyskin